Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,828 | -6,109 | -12,768 | -8,663 | -4,926 |
| Depreciation Amortization | 3 | 5 | 19 | 14 | 10 |
| Accounts receivable | N/A | N/A | 2,246 | 1,770 | -939 |
| Accounts payable and accrued liabilities | 246 | 150 | -311 | -619 | -578 |
| Other Working Capital | 1,182 | 282 | 2,035 | 761 | -1,268 |
| Other Operating Activity | 2,256 | 2,152 | -1,421 | -743 | 1,804 |
| Operating Cash Flow | $-7,140 | $-3,521 | $-10,200 | $-7,480 | $-5,898 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -1,500 | -1,500 | N/A | N/A | N/A |
| Other Investing Activity | -1,500 | -1,500 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,500 | $-1,500 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,073 | N/A | 28,773 | 28,742 | 28,335 |
| Other Financing Activity | 0 | 0 | -477 | -477 | -477 |
| Financing Cash Flow | $2,073 | $N/A | $28,296 | $28,265 | $27,858 |
| Beginning Cash Position | 29,214 | 29,214 | 11,119 | 11,119 | 11,119 |
| End Cash Position | 22,647 | 24,194 | 29,214 | 31,904 | 33,079 |
| Net Cash Flow | $-6,567 | $-5,021 | $18,096 | $20,785 | $21,961 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,140 | -3,521 | -10,200 | -7,480 | -5,898 |
| Free Cash Flow | -7,140 | -3,521 | -10,200 | -7,480 | -5,898 |